Skip to main content

Start your patients on the #1 prescribed prostacyclin treatment.1*

Learn more

FOR US HEALTHCARE PROFESSIONALS ONLY

For the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.

FOR US HEALTHCARE PROFESSIONALS ONLY

Request a Rep Referral Form
REFERRAL FORM

UNITED THERAPEUTICS CAREs™

Behind you all the way

United Therapeutics Cares™

Patient Navigators provide a United Therapeutics single point of contact for each patient

Our team will work with your patients to identify any potential obstacles to access and affordability and how we may be able to assist with overcoming them. Here’s how we can help:

  • Education & Expectations: Matching your patient with a Patient Navigator to keep them informed about what to expect in their treatment journey
  • Coverage & Reimbursement: Initiating the benefits investigation process and setting expectations on prior authorizations, appeals, and reimbursement needs
  • Cost & Savings: Sharing potential options, like co-pay and patient assistance programs, that may help with affording treatment
  • Prescription Coordination: Overseeing the referral process, working directly with Specialty Pharmacy Partners, to triage your patient’s prescription, confirm coverage, and monitor prescription status
  • Treatment Support: Checking in regularly and connecting patients to Patient Education Specialists, who can be an additional resource

Visit UnitedTherapeuticsCares.com for more information or reach out to the United Therapeutics Cares team directly at 1-844-864-8437. We’re ready to help Monday through Friday, 8:30 am to 7 pm ET.

United Therapeutics Cares Co-pay Assistance Program

MOST ELIGIBLE PATIENTS PAY AS LITTLE AS A $0 CO-PAY FOR EACH PRESCRIPTION OF TYVASO OR TYVASO DPI

Most eligible patients pay as little as a $0 co-pay for each prescription of TYVASO or TYVASO DPI

This program is valid only for the cost of the drug TYVASO or TYVASO DPI and not applicable to any related supplies or other medical expenses associated with administering the product.

The patient will be responsible for any remaining balance that is not covered by their initial $0 co-pay and the maximum program benefit.

PATIENT TERMS AND CONDITIONS

To enroll in the United Therapeutics Cares Co-Pay Assistance Program, your patients must understand and agree that they currently meet the eligibility criteria and will comply with the Terms and Conditions described below:

  • The Program is valid only for patients with commercial (also known as private) insurance who are taking the medication for an FDA-approved indication.
  • Patients using Medicare, Medicaid, or any other state or federal government program to pay for their medications are not eligible. Patients who start utilizing government coverage during the term of the Program will no longer be eligible. Eligible patients must be a resident of the US or Puerto Rico.
  • The Program is subject to additional state law restrictions. Patients residing in select states may not be eligible for the Program.
  • This Program is valid only for the cost of the drug and not applicable to any related supplies or other medical expenses associated with administering the product. This Program is not conditioned on any past, present, or future purchase, including refills.
  • Void where prohibited, taxed, or restricted by law.
  • The patient confirms that this Program is consistent with patient’s insurance. The patient is responsible for reporting the receipt of all Program benefits as required by the insurance company.
  • This Program is not insurance and is not intended to substitute for insurance.
  • Limit 1 (one) Program ID number per patient.
  • This ID number is non-transferable and has no value.
  • Patients, pharmacists, and prescribers cannot seek reimbursement from health insurance or any third party for any part of the benefit received by the patient through this offer.
  • United Therapeutics reserves the right to modify or terminate this Program at any time without notice.
  • By enrolling in the Program, you agree that your personal information may be used by United Therapeutics and its affiliates to send you information about United Therapeutics products, programs, support, and services related to your condition and contact you in connection with your participation in the Program and as provided in our Privacy Policy. United Therapeutics respects the privacy of your personal information and you may unsubscribe from our programs at any time by calling United Therapeutics Cares at 1-844-864-8437.

For full program details and Terms and Conditions, visit www.UTcopay.com.

Additional support for getting patients started

Regional Nurse Specialist (RNS)

A United Therapeutics RNS is available to help provide clinical education to providers, your care team and associated hospitals on PAH and TYVASO topics, including:

  • PAH screening and diagnosis
  • PAH disease state
  • Hands-on device training
  • Dosing and titration
  • Multidisciplinary education for offices and hospitals
  • AEs and possible mitigation and management strategies

Therapy Access Managers (TAMs)

TAMs provide education on payer requirements to help facilitate access and support reimbursement needs.

  • Offering resources to facilitate patient access to treatment
  • Supporting reimbursement and access questions for patients starting on therapy
  • Providing education on payer requirements for cases pending a prior authorization or appeal submission

Reach out to your United Therapeutics Cardiopulmonary Specialist for more information about these practice resources.